Genomics Collaborative sells DNA access to Celera:
This article was originally published in Clinica
Executive Summary
Celera Diagnostics has bought access to DNA sample sets associated with rheumatoid arthritis from functional genomics firm Genomics Collaborative of Cambridge, Massachusetts. Alameda, California-based Celera plans to analyse the samples to identify genetic markers, and will share resulting data with its partner.